FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer
In Brief: Justice Department Files Civil Suit To recover $25 Billion From Tobacco
ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application
UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says
Roferon A Application Marred By Mission Data, Protocol, Compliance
Underpowered Study Of Evacet Dashes Approval Hopes
NCI Programs: Institute Funds 24 DNA Microarray Centers
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- A new AI tool enables speedy use of ASCO guidelines, eliminating typical errors
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field









